Comments
The city-based Hetero has acquired a brownfield manufacturing unit at Penjerla in Telangana together with the land, plant and machinery in a slump sale from Johnson & Johnson Private Limited for nearly ₹130 crore..
The facility, spread across 55.27 acre, will be the flagship sterile pharmaceutical and biologics manufacturing unit bolstered by state-of-the-art technology for the pharma manufacturer.
“We are committed to an investment upwards of $75 million (approximately ₹600 crore) to upgrade and enhance existing facilities at the site and expand manufacturing of our global biologics and sterile pharmaceutical products,’‘ Vamsi Krishna Bandi, Managing Director, Hetero said in a release on Monday.
With this facility, Hetero aims to add 2,000 new jobs in biochemistry, pharmaceutical sciences, molecular biosciences, engineering, and ancillary services.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.